Diabetes Mellitus: all 11,090 studies
Page 31 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesCompletedNCT00791479Phase 2Results posted
- Study for Pre-Surgical Weight Loss in Type II Diabetes PatientsCompletedNCT00791128Phase 2Results posted
- Safety Study of Using Symlin Alongside Insulin in a Multiple Injection PortTerminatedNCT00790699Not applicableResults posted
- Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)CompletedNCT00790205Phase 3Results posted
- INTERPRET - International Report on Routine Practice of Sensor-enabled Pump TherapyCompletedNCT00790088Results posted
- Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusCompletedNCT00789750Phase 3Results posted
- Welchol as Monotherapy for Type 2 Diabetes MellitusCompletedNCT00789737Phase 3Results posted
- Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesCompletedNCT00789191Phase 3Results posted
- Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal TransplantCompletedNCT00788827Phase 1Results posted
- Opportunistic Screening for Prediabetes and Early Diabetes in Primary CareCompletedNCT00787839Results posted
- Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes MellitusCompletedNCT00787605Phase 4Results posted
- Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 DiabetesCompletedNCT00786019Not applicableResults posted
- Glucose Meter StudyCompletedNCT00782496Not applicableResults posted
- Response To Oral Agents in Diabetes (ROAD)- Pilot StudyCompletedNCT00780715Phase 4Results posted
- Improving Neuropathy and Mobility in People With Early DiabetesCompletedNCT00780559Not applicableResults posted
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell MassCompletedNCT00775684Not applicableResults posted
- Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes MellitusCompletedNCT00774800Phase 2Results posted
- Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsCompletedNCT00773279Phase 3Results posted
- Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.CompletedNCT00770653Phase 3Results posted
- Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With DiabetesCompletedNCT00770367Phase 4Results posted
- Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)TerminatedNCT00767000Phase 2Results posted
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes MellitusCompletedNCT00765817Phase 3Results posted
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneCompletedNCT00763815Phase 3Results posted
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCompletedNCT00763451Phase 3Results posted
- Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic FibrosisCompletedNCT00763412Not applicableResults posted
- The VA Diabetes Trial Follow-up Study (VADT-FS)CompletedNCT00756613Results posted
- Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.CompletedNCT00755846Phase 2Results posted
- An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' TrialCompletedNCT00754624Phase 2Results posted
- MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).CompletedNCT00754130Phase 1Results posted
- Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With MetforminCompletedNCT00753896Phase 3Results posted
- Multifactorial Pre-operative Intervention in Diabetes MellitusTerminatedNCT00753766Not applicableResults posted
- A Diabetes Study to Treat A Population Previously Not at TargetCompletedNCT00747149Phase 4Results posted
- Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate IntakeTerminatedNCT00747006Phase 2Results posted
- Treatment of Mild Gestational Diabetes With Glyburide Versus PlaceboCompletedNCT00744965Phase 4Results posted
- Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive PatientsCompletedNCT00744237Phase 4Results posted
- Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood GlucoseCompletedNCT00741390Not applicableResults posted
- A Crossover Study of the Acute Effects of Olanzapine in Healthy VolunteersCompletedNCT00741026Not applicableResults posted
- Diabetes Prevention and Control in the Workplace: A Pilot StudyCompletedNCT00739336Not applicableResults posted
- Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 DiabetesCompletedNCT00738023Phase 4Results posted
- Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic AdultsTerminatedNCT00737633Phase 2Results posted
- Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesCompletedNCT00736879Phase 3Results posted
- Vitamin D, Insulin Resistance, and Cardiovascular DiseaseCompletedNCT00736632Not applicableResults posted
- Follow-Up Study for ExuberaCompletedNCT00734591Results posted
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminCompletedNCT00734474Phase 2/3Results posted
- Aldosterone and Glucose HomeostasisCompletedNCT00732160Not applicableResults posted
- PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)TerminatedNCT00729365Phase 3Results posted
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a ThiazolidinedioneCompletedNCT00729326Phase 4Results posted
- Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.CompletedNCT00727857Phase 3Results posted
- MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)CompletedNCT00722371Phase 3Results posted
- Transitioning Open Heart Surgery Patients From Insulin Infusions to DetemirCompletedNCT00717288Phase 4Results posted
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal InsulinCompletedNCT00715624Phase 3Results posted
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of SulfonylureaCompletedNCT00713830Phase 3Results posted
- GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCompletedNCT00712673Phase 3Results posted
- Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsCompletedNCT00707993Phase 3Results posted
- Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic PatientsCompletedNCT00707954Phase 1/2Results posted
- Evaluation of a Primary Type 2 Diabetes Prevention ProgrammeCompletedNCT00707447Phase 4Results posted
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCompletedNCT00707031Phase 3Results posted
- Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)CompletedNCT00704132Phase 1Results posted
- Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With MetforminTerminatedNCT00701935Phase 2Results posted
- A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)CompletedNCT00701090Phase 3Results posted
- The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00700817Phase 3Results posted
- Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic ControlCompletedNCT00698932Phase 3Results posted
- A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and LiraglutideCompletedNCT00696657Phase 2Results posted
- Evaluation of a Diabetes Data Management SystemCompletedNCT00694070Results posted
- Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 DiabetesCompletedNCT00692237Phase 4Results posted
- Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic SyndromeCompletedNCT00690755Results posted
- Efficacy of Lubiprostone in Combination With Standard PEG PreparationTerminatedNCT00689026Not applicableResults posted
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in MonotherapyCompletedNCT00688701Phase 3Results posted
- Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone HealthCompletedNCT00679939Phase 4Results posted
- Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1CompletedNCT00678886Phase 3Results posted
- Mechanisms of Hypoglycemia Associated Autonomic FailureTerminatedNCT00678145Phase 2Results posted
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)CompletedNCT00676338Phase 3Results posted
- A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 DiabetesCompletedNCT00674986Not applicableResults posted
- A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin MonotherapyCompletedNCT00674466Phase 2Results posted
- Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on InsulinCompletedNCT00673231Phase 3Results posted
- Raptiva and Sirolimus in Islet Transplantation for Type 1 DiabetesTerminatedNCT00672204Phase 1/2Results posted
- Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinCompletedNCT00669864Phase 4Results posted
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 DiabeticsCompletedNCT00667732Phase 4Results posted
- A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsCompletedNCT00666718Phase 3Results posted
- Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light BreakfastCompletedNCT00664534Phase 4Results posted
- Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentCompletedNCT00663260Phase 2/3Results posted
- A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin LisproCompletedNCT00662857Phase 2Results posted
- Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 DiabetesCompletedNCT00661362Phase 3Results posted
- Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes PatientsCompletedNCT00660907Phase 3Results posted
- Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-RespondersCompletedNCT00660790Results posted
- A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes MellitusCompletedNCT00660309Phase 4Results posted
- Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 DiabetesCompletedNCT00660075Phase 3Results posted
- Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00659295Results posted
- Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 DiabetesCompletedNCT00659165Not applicableResults posted
- Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 DiabetesCompletedNCT00658021Phase 3Results posted
- Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.CompletedNCT00655863Phase 3Results posted
- Japanese P III vs Voglibose and PlaceboCompletedNCT00654381Phase 3Results posted
- Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 DiabetesCompletedNCT00645840Phase 1/2Results posted
- Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseTerminatedNCT00642616Phase 3Results posted
- Comparison of Blood Pressure Medications on MetabolismCompletedNCT00642434Phase 4Results posted
- An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 DiabetesCompletedNCT00642278Phase 2Results posted
- Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)CompletedNCT00642174Phase 2Results posted
- Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)CompletedNCT00641056Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin MonotherapyCompletedNCT00638716Phase 2Results posted
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)CompletedNCT00637273Phase 3Results posted